Advertisement
Advertisement
U.S. markets open in 8 hours 16 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.2223-0.0011 (-0.49%)
At close: 04:00PM EST
0.2375 +0.02 (+6.84%)
After hours: 07:53PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.2234
Open0.2155
Bid0.0000 x 1000
Ask0.0000 x 1000
Day's Range0.2019 - 0.2389
52 Week Range0.2000 - 3.3200
Volume3,964,352
Avg. Volume4,203,823
Market Cap32.223M
Beta (5Y Monthly)0.22
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CLVS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Clovis Oncology, Inc.
    DVAX: Lowering target price to $12.00DYNAVAX TECHNOLOGIES CORP has an Investment Rating of HOLD; a target price of $12.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement